Wordt geladen...

Regulation Catches Up to Reality: Nonadjunctive Use of Continuous Glucose Monitoring Data

The FDA recently conducted an Advisory Panel meeting to evaluate the safety, efficacy, and benefits of granting a nonadjunctive label claim for the DEXCOM G5 Mobile continuous glucose monitoring (CGM) system. If approved, this claim will allow users to make day-to-day treatment decisions, including...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Diabetes Sci Technol
Hoofdauteur: Edelman, Steven V.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: SAGE Publications 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5375077/
https://ncbi.nlm.nih.gov/pubmed/27630249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296816667749
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!